Division of Medical Microbiology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
J Antimicrob Chemother. 2018 Jul 1;73(7):1796-1803. doi: 10.1093/jac/dky121.
In this study, we characterize a concurrent disseminated infection with a virulent hypermucoviscous (HMV) Klebsiella pneumoniae and an OXA-181-producing XDR K. pneumoniae from a patient with recent hospitalization in India. During exposure to meropenem therapy, the highly susceptible HMV K. pneumoniae became resistant to carbapenems, consistent with the acquisition of blaOXA-181.
Twelve K. pneumoniae isolates were recovered from the patient and the hospital room environment over a 3 month hospitalization. Phenotypic and molecular studies were completed to characterize the isolates. Oxford Nanopore and Illumina MiSeq WGS were performed to study phylogeny (MLST and SNPs), plasmids and virulence genes and demonstrate changes in the organism's resistome that occurred over time.
WGS revealed that the HMV K. pneumoniae belonged to ST23 and harboured an IncH1B virulence plasmid, while the XDR K. pneumoniae belonged to ST147 and possessed two MDR plasmids (IncR and IncFII), the blaOXA-181-bearing ColKP3 plasmid and chromosomal mutations conferring the XDR phenotype. Sequential isolates demonstrated plasmid diversification (fusion of the IncR and IncFII plasmids), mobilization of resistance elements (ompK35 inactivation by ISEcp1-blaCTX-M-15 mobilization, varying numbers of resistance genes on plasmid scaffolds) and chromosomal mutations (mutations in mgrB) leading to further antibiotic resistance that coincided with antibiotic pressure. Importantly, the HMV strain in this study was unable to preserve the carbapenem-resistant phenotype without the selective pressure of meropenem.
To the best of our knowledge, we are the first to report a carbapenem-resistant HMV K. pneumoniae strain in the USA. Ultimately, this case demonstrates the role of antibiotic pressure in the acquisition and loss of important genetic elements.
本研究对一名近期在印度住院的患者同时感染了一株毒力较强的高黏液型(HMV)肺炎克雷伯菌和一株产 OXA-181 的广泛耐药(XDR)肺炎克雷伯菌进行了特征描述。在接触美罗培南治疗期间,高度敏感的 HMV 肺炎克雷伯菌对碳青霉烯类药物产生了耐药性,这与 blaOXA-181 的获得一致。
在该患者住院的 3 个月期间,从患者和医院病房环境中分离出了 12 株肺炎克雷伯菌。完成了表型和分子研究以对分离株进行特征描述。进行了牛津纳米孔和 Illumina MiSeq WGS 以研究系统发育(MLST 和 SNPs)、质粒和毒力基因,并证明了随着时间的推移,该生物体的耐药组发生了变化。
WGS 显示,HMV 肺炎克雷伯菌属于 ST23,携带 IncH1B 毒力质粒,而 XDR 肺炎克雷伯菌属于 ST147,拥有两个 MDR 质粒(IncR 和 IncFII)、携带 blaOXA-181 的 ColKP3 质粒和染色体突变赋予 XDR 表型。连续分离株显示出质粒多样化(IncR 和 IncFII 质粒融合)、耐药元件的转移(ompK35 失活通过 ISEcp1-blaCTX-M-15 转移,质粒支架上存在不同数量的耐药基因)和染色体突变(mgrB 突变)导致进一步的抗生素耐药性,这与抗生素压力有关。重要的是,在没有美罗培南选择压力的情况下,本研究中的 HMV 菌株无法保持碳青霉烯类药物耐药表型。
据我们所知,我们是美国第一家报告碳青霉烯类耐药 HMV 肺炎克雷伯菌的机构。最终,该病例表明了抗生素压力在获得和丧失重要遗传元件方面的作用。